Format

Send to

Choose Destination
Haematologica. 2019 Apr 19. pii: haematol.2018.215616. doi: 10.3324/haematol.2018.215616. [Epub ahead of print]

Impact of corticosteroid pretreatment in pediatric patients with newly diagnosed B-lymphoblastic leukemia: a report from the Children's Oncology Group.

Author information

1
Dept. of Pediatrics and Perlmutter Cancer Center, NYU Langone Health, New York, USA; elizabeth.raetz@nyulangone.org.
2
Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, USA.
3
Department of Biostatistics, University of Florida, Gainesville, Florida, USA.
4
Department of Pediatrics, Children's Hospital Colorado, Aurora, USA.
5
HARP Pharma Consulting, Mystic, CT, USA.
6
Department of Pediatrics, Maine Children Cancer Program, Scarborough, ME, USA.
7
Department of Genetics, University of Alabama at Birmingham, Birmingham, AL, USA.
8
Dept. of of Pathology, Wexner Medical Center, Ohio State University, Columbus, OH, USA.
9
Dept. of Pathology and Pediatrics,Nationwide Children's Hospital,Ohio State University,Columbus,USA.
10
Departments of Pathology and Medicine, University of Washington, Seattle, WA, USA.
11
Departments of Pathology and Oncology, Johns Hopkins Medical Institutions, Baltimore, MD, USA.
12
Departments of Pediatrics, UT Southwestern, Dallas, TX, USA.
13
Children Hospital of Philadelphia, University of Pennsylvania, Philadelphia, USA.
14
Dept. of Pediatrics and Perlmutter Cancer Center, NYU Langone Health, New York, USA.

KEYWORDS:

Corticosteroid; Pediatric Acute Lymphoblastic Leukemia; Pretreatment

PMID:
31004024
DOI:
10.3324/haematol.2018.215616
Free full text

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center